Visual acuity reduced transiently
(UMLS:C0852720)
- UMLS ID:
- C0852720
- MeSH ID:
- N/A
Synonym(s)
1.
Visual acuity reduced transiently
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | teriflunomide | FAERS: 5 | US FAERS | |
| 2 | Restasis | FAERS: 4 | US FAERS | |
| 3 | Topiramate | FAERS: 4 | US FAERS | |
| 4 | Moxifloxacin | FAERS: 3 | US FAERS | |
| 5 | atovaquone, proguanil drug combination | FAERS: 3 | OFFSIDES US FAERS | |
| 6 | Citalopram | FAERS: 2 | US FAERS | |
| 7 | Clopidogrel | FAERS: 2 | US FAERS | |
| 8 | Dabigatran | FAERS: 2 | US FAERS | |
| 9 | Sildenafil Citrate | FAERS: 2 | US FAERS | |
| 10 | Teriparatide | FAERS: 2 | US FAERS | |
| 11 | Vardenafil Dihydrochloride | FAERS: 2 | US FAERS | |
| 12 | gadoteridol | FAERS: 2 | OFFSIDES US FAERS | |
| 13 | Celecoxib | FAERS: 1 | US FAERS | |
| 14 | Ciprofloxacin | FAERS: 1 | US FAERS | |
| 15 | Desogestrel | FAERS: 1 | US FAERS | |
| 16 | Doxorubicin | FAERS: 1 | US FAERS | |
| 17 | Enalapril | FAERS: 1 | US FAERS | |
| 18 | Ezetimibe | FAERS: 1 | US FAERS | |
| 19 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 20 | Gabapentin | FAERS: 1 | US FAERS | |
| 21 | Ibuprofen | FAERS: 1 | US FAERS | |
| 22 | Milnacipran | FAERS: 1 | US FAERS | |
| 23 | Norgestrel | FAERS: 1 | US FAERS | |
| 24 | Ranolazine | FAERS: 1 | US FAERS | |
| 25 | Rosiglitazone | FAERS: 1 | US FAERS | |
| 26 | Simbrinza | FAERS: 1 | US FAERS | |
| 27 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 28 | Tadalafil | FAERS: 1 | US FAERS | |
| 29 | Thyroxine | FAERS: 1 | US FAERS | |
| 30 | Verteporfin | FAERS: 1 | US FAERS | |
| 31 | bepotastine | FAERS: 1 | US FAERS | |
| 32 | liposomal doxorubicin | FAERS: 1 | US FAERS | |
| 33 | pirfenidone | FAERS: 1 | US FAERS | |
| 34 | Scopolamine | OFFSIDES | ||
| 35 | imidapril | OFFSIDES | ||
| 36 | methenolone acetate | OFFSIDES | ||
| 37 | sennoside A&B | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.